Bernhard Englinger, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ependymoma | 6 | 2024 | 334 | 1.420 |
Why?
|
Chromosomes, Human, Y | 1 | 2023 | 148 | 0.870 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 4 | 2021 | 250 | 0.870 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2021 | 185 | 0.760 |
Why?
|
Indoles | 4 | 2018 | 1839 | 0.750 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5172 | 0.750 |
Why?
|
Pyridazines | 2 | 2020 | 202 | 0.670 |
Why?
|
Coordination Complexes | 1 | 2018 | 115 | 0.590 |
Why?
|
Receptors, Endothelin | 1 | 2016 | 58 | 0.570 |
Why?
|
Dioxoles | 1 | 2017 | 104 | 0.570 |
Why?
|
Tetrahydroisoquinolines | 1 | 2017 | 91 | 0.560 |
Why?
|
Cullin Proteins | 1 | 2017 | 180 | 0.540 |
Why?
|
Imidazoles | 2 | 2020 | 1206 | 0.490 |
Why?
|
Metals | 1 | 2018 | 719 | 0.480 |
Why?
|
Cisplatin | 1 | 2017 | 1662 | 0.370 |
Why?
|
Lung Neoplasms | 4 | 2020 | 13102 | 0.370 |
Why?
|
Organoplatinum Compounds | 2 | 2019 | 408 | 0.300 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13695 | 0.260 |
Why?
|
Brain Neoplasms | 3 | 2023 | 8863 | 0.260 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16689 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 2 | 2020 | 5535 | 0.240 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3557 | 0.230 |
Why?
|
Glioma | 3 | 2023 | 3401 | 0.230 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2022 | 17 | 0.220 |
Why?
|
Vaccinia | 1 | 2022 | 76 | 0.210 |
Why?
|
Supratentorial Neoplasms | 1 | 2023 | 160 | 0.200 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6773 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9239 | 0.170 |
Why?
|
HCT116 Cells | 2 | 2017 | 408 | 0.170 |
Why?
|
Photochemical Processes | 1 | 2018 | 84 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6364 | 0.160 |
Why?
|
Riboflavin | 1 | 2018 | 108 | 0.160 |
Why?
|
Cell Proliferation | 6 | 2020 | 10481 | 0.160 |
Why?
|
Comparative Genomic Hybridization | 2 | 2016 | 496 | 0.150 |
Why?
|
Fluorocarbons | 1 | 2023 | 452 | 0.150 |
Why?
|
Endoplasmic Reticulum | 1 | 2023 | 1144 | 0.150 |
Why?
|
Urinary Bladder | 1 | 2023 | 1172 | 0.150 |
Why?
|
Depsipeptides | 1 | 2017 | 94 | 0.150 |
Why?
|
Nanoparticles | 2 | 2018 | 1905 | 0.150 |
Why?
|
G-Quadruplexes | 1 | 2019 | 162 | 0.140 |
Why?
|
Prodrugs | 1 | 2018 | 268 | 0.140 |
Why?
|
Macrolides | 1 | 2017 | 201 | 0.140 |
Why?
|
Arsenicals | 1 | 2016 | 124 | 0.130 |
Why?
|
DNA Methylation | 3 | 2020 | 4286 | 0.130 |
Why?
|
Thiosemicarbazones | 1 | 2015 | 15 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 2 | 2021 | 895 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2024 | 2649 | 0.130 |
Why?
|
Fluorescence | 1 | 2017 | 751 | 0.130 |
Why?
|
Liposomes | 1 | 2018 | 759 | 0.130 |
Why?
|
Epigenomics | 1 | 2020 | 903 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
Oxides | 1 | 2016 | 405 | 0.120 |
Why?
|
DNA | 2 | 2019 | 7301 | 0.120 |
Why?
|
Genes, p53 | 1 | 2017 | 755 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 2015 | 252 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1017 | 0.120 |
Why?
|
Drug Synergism | 1 | 2017 | 1792 | 0.110 |
Why?
|
Neoplasms | 3 | 2018 | 21683 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 850 | 0.110 |
Why?
|
Osteosarcoma | 1 | 2018 | 881 | 0.110 |
Why?
|
Cell Survival | 3 | 2018 | 5882 | 0.110 |
Why?
|
Light | 1 | 2018 | 1374 | 0.110 |
Why?
|
Lysosomes | 1 | 2017 | 893 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8428 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 578 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3586 | 0.100 |
Why?
|
Antimalarials | 1 | 2018 | 905 | 0.100 |
Why?
|
Signal Transduction | 3 | 2020 | 23403 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2617 | 0.090 |
Why?
|
Cell Separation | 1 | 2016 | 1751 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3505 | 0.090 |
Why?
|
Humans | 24 | 2024 | 744343 | 0.090 |
Why?
|
Protein Kinase C | 1 | 2015 | 1227 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 1917 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2018 | 2969 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2219 | 0.080 |
Why?
|
Histones | 3 | 2024 | 2599 | 0.080 |
Why?
|
Mice | 6 | 2022 | 81183 | 0.080 |
Why?
|
Mice, SCID | 3 | 2018 | 2716 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3798 | 0.070 |
Why?
|
DNA Repair | 1 | 2017 | 2046 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3481 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.070 |
Why?
|
Pyridines | 2 | 2016 | 2825 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2016 | 5974 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4253 | 0.060 |
Why?
|
Animals | 8 | 2022 | 168757 | 0.060 |
Why?
|
Child | 6 | 2024 | 77709 | 0.060 |
Why?
|
Thapsigargin | 1 | 2023 | 104 | 0.060 |
Why?
|
Immunotherapy | 1 | 2018 | 4445 | 0.060 |
Why?
|
Rhombencephalon | 1 | 2023 | 85 | 0.050 |
Why?
|
Transcription Factor RelA | 1 | 2023 | 275 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2021 | 105 | 0.050 |
Why?
|
Vaccinia virus | 1 | 2022 | 349 | 0.050 |
Why?
|
Methionine | 1 | 2022 | 590 | 0.050 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2019 | 220 | 0.040 |
Why?
|
Nervous System | 1 | 2022 | 554 | 0.040 |
Why?
|
Cilia | 1 | 2023 | 466 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6386 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9856 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 6314 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16365 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2023 | 1185 | 0.040 |
Why?
|
Lysine | 1 | 2023 | 1007 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2023 | 783 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2018 | 139 | 0.040 |
Why?
|
Integrins | 1 | 2022 | 846 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2017 | 418 | 0.030 |
Why?
|
Plasmids | 1 | 2021 | 2307 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2022 | 1005 | 0.030 |
Why?
|
Biological Transport | 1 | 2020 | 2118 | 0.030 |
Why?
|
Keratinocytes | 1 | 2019 | 798 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2017 | 592 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9438 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2327 | 0.030 |
Why?
|
Drug Design | 1 | 2018 | 1076 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2915 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1401 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 2994 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9727 | 0.020 |
Why?
|
Colon | 1 | 2017 | 1772 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5456 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
Plasmodium falciparum | 1 | 2018 | 1732 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 6103 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1972 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3279 | 0.020 |
Why?
|
Genomics | 1 | 2020 | 5720 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11483 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7186 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7474 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9338 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
Adult | 1 | 2020 | 214055 | 0.000 |
Why?
|
Male | 1 | 2020 | 350118 | 0.000 |
Why?
|
Female | 1 | 2020 | 380194 | 0.000 |
Why?
|